ANN ARBOR, Mich., April 25, 2017 /PRNewswire-iReach/ -- Genomenon® Inc., a genomic interpretation software company, today
"This grant recognizes the solid approach and great potential of Genomenon's technology to drive rapid improvements in automating accurate gene and variant curation" Genomenon co- founder and CSO Dr. Mark Kiel said.
Genomenon's initial product, Mastermind, is a novel analytic and data visualization tool that accelerates gene and variant curation by providing immediate insight into millions of scientific articles from the primary medical literature. The grant will help Genomenon in its quest to assemble the most comprehensive database of genomic knowledge ever created by expanding its Mastermind database with millions of additional articles covering genetic disease.
The funds for Phase I of this grant will be used to perform concordance testing between the Mastermind database and current gold-standard references of genomic knowledge. Phase II will focus on refining various applications using the Mastermind database including the development of ancillary software to inform patient diagnosis and research discovery.
Genomenon recently announced the completion of its latest financing round in the 4th quarter of 2016. The financing fueled the completion and launch of Mastermind, which was officially released in February.
Research reported in this publication was supported by the National Human Genome Research Institute of the National Institutes of Health under Award Number R44HG009474. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Genomenon has eliminated the manual search process for gene and variant curation with a scientific literature database and software for use in clinical decision-making. We have mined the full text of millions of genomic-related scientific articles to create a comprehensive genomic knowledge base that enables pathologists and geneticists to quickly and accurately curate disease-causing variants from genomic-sequencing datasets. With the comprehensive dataset and deep insight into the genomic literature, we're able to provide fascinating results – from accelerated gene and variant curation to evidence-based panel design – by scouring the literature to find genes and variants linked to specific diseases within the literature.
For more information, visit www.genomenon.com or email firstname.lastname@example.org
Media Contact: Jessica Francis, Genomenon, 4408404987, email@example.com
News distributed by PR Newswire iReach: https://ireach.prnewswire.com
Subscribe to our Free Newsletters!
Age related macular degeneration is a disease of the elderly, wherein the macula or the central ...
It is time to enjoy the cool weather with the advent of the rains. Along with fun, one should also ...
Learn the basics about diabetes and how to bring it under control with turmeric, an highly ...View All